Significant decrease in quality of life in patients with pemphigus vulgaris: Results from the German Bullous Skin Disease (BSD) study group;Deutliche einschränkung der lebensqualität bei patienten mit pemphigus vulgaris: Ergebnisse der Deutschen Bullous Skin Disease (BSD)-studiengruppe

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 6, 2005, Pages 431-435

  Mayrshofer, Franziska ^a   Hertl, Michael ^a,g   Sinkgraven, Ronald ^b   Sticherling, Michael ^c   Pfeiffer, Christiane ^d   Zillikens, Detlef ^e   Messer, Gerald ^f   Rzany, Berthold ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Autoantibody; Autoimmunity; Desmosome; Inflammation; Skin; Therapy

Indexed keywords

AUTOANTIBODY;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DERMATOLOGY LIFE QUALITY INDEX QUESTIONNAIRE; DESMOSOME; GERMANY; HUMAN; INFLAMMATION; MEDICAL SOCIETY; MUCOSA; PAIN; PEMPHIGUS VULGARIS; QUALITY OF LIFE; QUESTIONNAIRE; REGISTER; SCORING SYSTEM; SKIN; UNIVERSITY HOSPITAL; COMPARATIVE STUDY; FEMALE; MALE; MIDDLE AGED; PEMPHIGUS;

ADULT; AGED; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 21244473925     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2005.05722.x     Document Type: Article

References (13)

1. Amagai M, Klaus-Kovtun V, Stanley JR. Auto-Ab against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67: 869-877.
2. Huilgol SC, Black MM. Management of the immunbullous disorders. II. Pemphigus. Clin Exp Dermatol 1995; 20: 283-293.
3. Herd M, Schuler G. Bullöse Autoimmundermatosen Teil 2: Pathogenese. Hautarzt 2002; 53: 277-285.
4. Mahoney MG, Wang Z, Rothenberger KL, Koch PJ, Amagai M, Stanley JR. Explanation for localization of blisters in pemphigus patients. J Clin Invest 1999; 103: 461-468.
5. Scully C, Paes de Almeida O, Porter R, Gilkes JJH. Pemphigus vulgaris: the manifestation and long-term management of 55 patients with oral lesions. Br J Dermatol 1999; 140: 84-89.
6. Hodak E, Kremer I, David M. Conjunktival involvement in pemphigus vulgaris: a clinical, histopathological and immunfluorescence study. Br J Dermatol 1990; 123: 615-620.
7. Hertl M, Schuler G. Bullöse Autoimmundermatosen Teil 1: Klassifikation. Hautarzt 2002; 53: 207-221.
8. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
9. Hertl M, Schuler G. Bullöse Autoimmundermatosen Teil 3: Diagnostik und Therapie. Hautarzt 2002; 53: 352-366.
10. Rzany B, Partscht K, Kippes W, Ettrich A, Baima B, Pawelczyk A, Prudlo C, Jung M, Mecking D, Schuhmann M, Büdinger L, Kaiser HW, Meurer M, Zillikens D, Hertl M, Sticherling M, Messer G, Pfeiffer C. Quality of Life in Patients with Bullous Pemphigold in Germany. J Invest Dermatol 2000; 114: 887.
11. Hiltscher D, Boslet W TH, Sinkgraven R, Rzany B. Lebensqualität bei Patienten mit Rosacea und Rhinophym. Akt Dermatol 2001; 27: 391-394.
12. Yancey KB, Egan CA. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA 2000; 19: 350-356.
13. Schiffner R, Schiffner-Rohe J, Landthaler M, Stolz W. Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids. Pharmacoeconomics 2003; 21: 159-79.